Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : L-Glutamine
Therapeutic Area : Gastroenterology
Study Phase : Phase I
Sponsor : Emmaus Life Sciences
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : Emmaus Life Sciences has engaged Partner International to lead the out-licensing activity for Emmaus’ prescription grade L-glutamine (PGLG) oral powder for use in the treatment of diverticulosis.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
July 16, 2020
Lead Product(s) : L-Glutamine
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I
Sponsor : Emmaus Life Sciences
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Reset All
